FDA NDC Directory · JSON-LD · Markdown

Trijardy XR

NDC 0597-0380 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nameempagliflozin, linagliptin, metformin hydrochloride
Labeler / ManufacturerBoehringer Ingelheim Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA212614
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsEMPAGLIFLOZIN (10 mg/1)
LINAGLIPTIN (5 mg/1)
METFORMIN HYDROCHLORIDE (1000 mg/1)
Marketing started20200423
Package count2

External sources

Source: openFDA. Public-domain (CC0).